Efficient gene delivery and silencing of mouse and human pancreatic islets
1 Univ Lille Nord de France, F-59000 Lille, France
2 INSERM U859, F-59000 Lille, France
3 CHU Lille, F-59000 Lille, France
4 Center for Biomolecular Interactions Bremen, University of Bremen, Germany
BMC Biotechnology 2010, 10:28 doi:10.1186/1472-6750-10-28Published: 30 March 2010
In view of the importance of beta cells in glucose homeostasis and the profound repercussions of beta cell pathology on human health, the acquisition of tools to study pancreatic islet function is essential for the design of alternative novel therapies for diabetes. One promising approach toward this goal involves the modification of gene expression profile of beta cells.
This study describes a new method of gene and siRNA delivery into human pancreatic islets by microporation technology. We demonstrated that mild islet distention with accutase greatly enhanced the transfection efficiency without compromising in vitro function (secretion, apoptosis and viability). As an example, the recently identified gene involved in type 2 diabetes, ZnT8, can be over-expressed or silenced by RNA interference using this technology. Microporation can also be used on rodent islets.
Taken together, our results demonstrate that microporation technology can be used to modify gene expression in whole rodent and human islets without altering their in vitro function and will be key to the elucidation of the factors responsible for proper islet function.